Variegation of autism related traits across seven neurogenetic disorders

Nancy Raitano Lee, Xin Niu, Fengqing Zhang, Liv S Clasen, Beth A Kozel, Ann C M Smith, Gregory L Wallace, Armin Raznahan, Nancy Raitano Lee, Xin Niu, Fengqing Zhang, Liv S Clasen, Beth A Kozel, Ann C M Smith, Gregory L Wallace, Armin Raznahan

Abstract

Gene dosage disorders (GDDs) constitute a major class of genetic risks for psychopathology, but there is considerable debate regarding the extent to which different GDDs induce different psychopathology profiles. The current research speaks to this debate by compiling and analyzing dimensional measures of several autism-related traits (ARTs) across seven diverse GDDs. The sample included 350 individuals with one of 7 GDDs, as well as reference idiopathic autism spectrum disorder (ASD; n = 74) and typically developing control (TD; n = 171) groups. The GDDs were: Down, Williams-Beuren, and Smith-Magenis (DS, WS, SMS) syndromes, and varying sex chromosome aneuploidies ("plusX", "plusXX", "plusY", "plusXY"). The Social Responsiveness Scale (SRS-2) was used to measure ARTs at different levels of granularity-item, subscale, and total. General linear models were used to examine ART profiles in GDDs, and machine learning was used to predict genotype from SRS-2 subscales and items. These analyses were completed with and without covariation for cognitive impairment. Twelve of all possible 21 pairwise GDD group contrasts showed significantly different ART profiles (7/21 when co-varying for IQ, all Bonferroni-corrected). Prominent GDD-ART associations in post hoc analyses included relatively preserved social motivation in WS and relatively low levels of repetitive behaviors in plusX. Machine learning revealed that GDD group could be predicted with plausible accuracy (~60-80%) even after controlling for IQ. GDD effects on ARTs are influenced by GDD subtype and ART dimension. This observation has consequences for mechanistic, clinical, and translational aspects of psychiatric neurogenetics.

Trial registration: ClinicalTrials.gov NCT00001246 NCT00013559.

Conflict of interest statement

The authors declare no competing interests.

© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Figures

Fig. 1. Synopsis of results from pairwise…
Fig. 1. Synopsis of results from pairwise mixed model ANOVAs (above diagonal) and ANCOVAs with cognitive impairment covaried (below diagonal).
To test for differential ART subscale profiles between each unique pair of GDD groups, we ran 21 (number of unique GDD group pairings) 2 (GDD group) × 5 (SRS-2 subscale) mixed-model ANOVAs. For these analyses, group effects (e.g., GDD 1 is more or less impaired overall than GDD 2 on the SRS-2 subscales) and group*subscale interaction effects (e.g., there is a difference in the SRS-2 profile for GDD 1 vs. GDD 2) were evaluated and results are presented above the diagonal. Parallel analyses were also completed using ANCOVA including cognitive impairment as a covariate and results are presented below the diagonal. When interpreting the figure, note the following. Main effects of group were denoted with a ‘G’; group*scale interactions were denoted with an ‘I’. Instances in which there was a main effect of group or group*scale interaction that did not survive Bonferroni correction are denoted with a single asterisk (*p < 0.05); those that survived Bonferroni correction are denoted with a double asterisk (**p < 0.05—Bonferroni corrected). Finally, to aid interpretation, color coding was implemented as follows. When a main effect of group was identified that survived Bonferroni correction, the cell in the matrix was color coded blue. When there was a Bonferroni-corrected group*subscale interaction, the cell was color coded yellow. Instances in which there was both a main effect of group (magnitude of impairment) and a group* subscale interaction (SRS-2 profile difference) following Bonferroni correction were color coded green.
Fig. 2. Gene dosage disorder (GDD) scores…
Fig. 2. Gene dosage disorder (GDD) scores for different autism-related traits (ARTs).
Top panel: Point-line graph showing score profiles for each GDD across ARTs. Color encodes group. GDDs are in solid lines, and the benchmark autism spectrum disorder (ASD) and healthy volunteer (HV) groups are in dashed lines. Middle panel: Boxplots for each ART showing GDD group score distributions. Bottom panel: Heatmaps for each ART showing Cohen’s d effect sizes for all pairwise GDD group comparisons (column group vs. row group). Asterisks denote statistically significant comparisons (*nominal p < 0.05, **surviving Bonferroni correction for multiple comparisons).
Fig. 3. Autism-related trait (ART) scores for…
Fig. 3. Autism-related trait (ART) scores for different gene dosage disorders (GDDs).
Top panel: Point-line graph showing score profiles for each ART across GDDs. Colored solid lines encode ARTs. Cognitive impairment scores are shown as a reference (dashed gray). Middle panel: Boxplots for each GDD showing score distributions for each ART. Bottom panel: Heatmaps for each GDD showing Cohen’s d effect sizes for all pairwise ART comparisons (column group vs. row group). Asterisks denote statistically significant comparisons (*nominal p < 0.05, **surviving Bonferroni correction for multiple comparisons).
Fig. 4. Relationships between autism-related trait (ART)…
Fig. 4. Relationships between autism-related trait (ART) scores and cognitive impairment within each gene dosage disorder (GDD).
Scatterplots and linear fit lines showing the relationship between increasing cognitive impairment (x-axis: “IQ_as_Tscore”) and ART score value (y-axis) faceted by GDD (rows) and ART subscale (columns). Robust correlation coefficients are provided for each cell. Color encodes GDD. Dashed lines show population norm values (50, black) and 2 standard deviations above this norm (70, gray). Note that IQ is inverted and transformed to a distribution with mean = 50, sd = 10 to form “IQ_as_Tscore” (i.e., IQ_as_Tscore > 70 is equivalent to IQ < 70).
Fig. 5. Average prediction accuracy for each…
Fig. 5. Average prediction accuracy for each GDD group achieved by each of the four machine learning (ML) models.
All the models yield plausible (above chance) prediction accuracy. Without IQ, group LASSO with 65 items performs better than LASSO with 5 subscales for most of the GDD groups except WS where their prediction accuracies are similar. With IQ information, the comparison of ML model performance with 65 items vs. 5 subscales varies across the GDD groups. The error bar indicates 95% confidence interval of the 1000 bootstrap samples across the 5-fold cross-validation.
Fig. 6. Feature importance for the LASSO…
Fig. 6. Feature importance for the LASSO model with IQ included.
The coloring represents both the feature importance and the direction of feature effect. Positive values indicate an increased likelihood of a certain GDD group while negative values suggest a reduced probability of a certain GDD group. Higher absolute values (i.e., feature importance values) indicate greater consistency of a feature being selected as an important predictor to improve prediction accuracy across the 5-fold cross-validation. Awareness is consistently selected as an important predictor for SMS and PLUSX. Cognition is consistently selected for predicting SMS and WS. Motivation is consistently selected for predicting WS, PLUSX, and PLUSY. RIRB is consistently selected for predicting SMS and DS.

References

    1. Levy RJ, Xu B, Gogos JA, Karayiorgou M. Copy number variation and psychiatric disease risk. Methods Mol Biol. 2012;838:97–113.
    1. Sanders SJ, Sahin M, Hostyk J, Thurm A, Jacquemont S, Avillach P, et al. A framework for the investigation of rare genetic disorders in neuropsychiatry. Nat Med. 2019;25:1477–87.
    1. Moreau CA, Raznahan A, Bellec P, Chakravarty M, Thompson PM, Jacquemont S. Dissecting autism and schizophrenia through neuroimaging genomics. Brain. 2021;144:1943–57.
    1. Chawner S, Doherty JL, Anney RJL, Antshel KM, Bearden CE, Bernier R, et al. A genetics-first approach to dissecting the heterogeneity of autism: phenotypic comparison of autism risk copy number variants. Am J Psychiatry. 2021;178:77–86.
    1. Oliver C, Berg K, Moss J, Arron K, Burbidge C. Delineation of behavioral phenotypes in genetic syndromes: characteristics of autism spectrum disorder, affect and hyperactivity. J Autism Dev Disord. 2011;41:1019–32.
    1. Raznahan A. Editorial: do different neurogenetic disorders impart different profiles of psychiatric risk? J Am Acad Child Adolesc Psychiatry. 2020;59:1022–4.
    1. Constantino JN, Gruber CP. Social responsiveness scale-2nd edition. Torrance, CA: Western Psychological Services; 2012.
    1. Constantino JN, Todd RD. Autistic traits in the general population: a twin study. Arch Gen Psychiatry. 2003;60:524–30.
    1. Huke V, Turk J, Saeidi S, Kent A, Morgan JF. Autism spectrum disorders in eating disorder populations: a systematic review. Eur Eat Disord Rev. 2013;21:345–51.
    1. Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N. Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry. 2009;48:10–8.
    1. Reiersen AM, Constantino JN, Volk HE, Todd RD. Autistic traits in a population-based ADHD twin sample. J Child Psychol Psychiatry. 2007;48:464–72.
    1. Cooper M, Martin J, Langley K, Hamshere M, Thapar A. Autistic traits in children with ADHD index clinical and cognitive problems. Eur Child Adolesc Psychiatry. 2014;23:23–34.
    1. Kenworthy L, Case L, Harms MB, Martin A, Wallace GL. Adaptive behavior ratings correlate with symptomatology and IQ among individuals with high-functioning autism spectrum disorders. J Autism Dev Disord. 2010;40:416–23.
    1. Mito H, Matsuura N, Mukai K, Yanagisawa Y, Nakajima A, Motoyama M, et al. The impacts of elevated autism spectrum disorder traits on clinical and psychosocial features and long-term treatment outcome in adult patients with obsessive-compulsive disorder. Compr Psychiatry. 2014;55:1526–33.
    1. Ziermans TB, Schirmbeck F, Oosterwijk F, Geurts HM, de Haan L, Genetic R, et al. Autistic traits in psychotic disorders: prevalence, familial risk, and impact on social functioning. Psychol Med. 2020;51:1704–13.
    1. Happe F, Ronald A. The ‘fractionable autism triad’: a review of evidence from behavioural, genetic, cognitive and neural research. Neuropsychol Rev. 2008;18:287–304.
    1. Robinson EB, Koenen KC, McCormick MC, Munir K, Hallett V, Happe F, et al. A multivariate twin study of autistic traits in 12-year-olds: testing the fractionable autism triad hypothesis. Behav Genet. 2012;42:245–55.
    1. Kou Y, Betancur C, Xu H, Buxbaum JD, Ma’ayan A. Network- and attribute-based classifiers can prioritize genes and pathways for autism spectrum disorders and intellectual disability. Am J Med Genet C Semin Med Genet. 2012;160C:130–42.
    1. Nishiyama T, Taniai H, Miyachi T, Ozaki K, Tomita M, Sumi S. Genetic correlation between autistic traits and IQ in a population-based sample of twins with autism spectrum disorders (ASDs) J Hum Genet. 2009;54:56–61.
    1. Yap CX, Alvares GA, Henders AK, Lin T, Wallace L, Farrelly A, et al. Analysis of common genetic variation and rare CNVs in the Australian Autism Biobank. Mol Autism. 2021;12:12.
    1. Mayes SD, Calhoun SL. Impact of IQ, age, SES, gender, and race on autistic symptoms. Res Autism Spectr Disord. 2011;5:749–57.
    1. Lee NR, Anand P, Will E, Adeyemi EI, Clasen LS, Blumenthal JD, et al. Everyday executive functions in Down syndrome from early childhood to young adulthood: evidence for both unique and shared characteristics compared to youth with sex chromosome trisomy (XXX and XXY) Front Behav Neurosci. 2015;9:264.
    1. Kopp ND, Parrish PCR, Lugo M, Dougherty JD, Kozel BA. Exome sequencing of 85 Williams-Beuren syndrome cases rules out coding variation as a major contributor to remaining variance in social behavior. Mol Genet Genom Med. 2018;6:749–65.
    1. Lugo M, Wong ZC, Billington CJ, Jr, Parrish PCR, Muldoon G, Liu D, et al. Social, neurodevelopmental, endocrine, and head size differences associated with atypical deletions in Williams–Beuren syndrome. Am J Med Genet A. 2020;182:1008–20.
    1. van Rijn S, Stockmann L, Borghgraef M, Bruining H, van Ravenswaaij-Arts C, Govaerts L, et al. The social behavioral phenotype in boys and girls with an extra X chromosome (Klinefelter syndrome and Trisomy X): a comparison with autism spectrum disorder. J Autism Dev Disord. 2014;44:310–20.
    1. Gulsrud A, Lin CE, Park MN, Hellemann G, McCracken J. Self-injurious behaviours in children and adults with autism spectrum disorder (ASD) J Intellect Disabil Res. 2018;62:1030–42.
    1. Tibshirani R. Regression Shrinkage and Selection via the Lasso. J R Stat Soc Ser B (Methodol) 1996;58:267–88.
    1. Yuan M, Lin Y. Model selection and estimation in regression with grouped variables. J R Stat Soc: Ser B (Stat Methodol) 2006;68:49–67.
    1. Zhang F, Wang J-P, Jiang W. An integrative classification model for multiple sclerosis lesion detection in multimodal MRI. Stat Its Interface. 2019;12:193–202.
    1. Zhang F, Tapera TM, Gou J. Application of a new dietary pattern analysis method in nutritional epidemiology. BMC Med Res Methodol. 2018;18:119.
    1. Ogutu JO, Piepho HP. Regularized group regression methods for genomic prediction: Bridge, MCP, SCAD, group bridge, group lasso, sparse group lasso, group MCP and group SCAD. BMC Proc. 2014;8(Suppl 5):S7.
    1. Fan J, Lv J, Qi L. Sparse high dimensional models in economics. Annu Rev Econ. 2011;3:291–317.
    1. He H, Garcia EA. Learning from imbalanced data. IEEE Trans Knowl Data Eng. 2009;21:1263–84.
    1. Sun Y, Wong AKC, Kamel MS. Classification of imbalanced data: a review. Int J Pattern Recognit Artif Intell. 2009;23:687–719.
    1. Lee NR, Wallace GL, Adeyemi EI, Lopez KC, Blumenthal JD, Clasen LS, et al. Dosage effects of X and Y chromosomes on language and social functioning in children with supernumerary sex chromosome aneuploidies: implications for idiopathic language impairment and autism spectrum disorders. J Child Psychol Psychiatry. 2012;53:1072–81.
    1. Ozonoff S, Jensen J. Brief report: specific executive function profiles in three neurodevelopmental disorders. J Autism Dev Disord. 1999;29:171–7.
    1. Royston R, Oliver C, Moss J, Adams D, Berg K, Burbidge C, et al. Brief Report: repetitive behaviour profiles in williams syndrome: cross syndrome comparisons with Prader–Willi and Down syndromes. J Autism Dev Disord. 2018;48:326–31.
    1. Richards C, Jones C, Groves L, Moss J, Oliver C. Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2015;2:909–16.
    1. Laje G, Morse R, Richter W, Ball J, Pao M, Smith AC. Autism spectrum features in Smith–Magenis syndrome. Am J Med Genet C Semin Med Genet. 2010;154C:456–62.
    1. Martin SC, Wolters PL, Smith AC. Adaptive and maladaptive behavior in children with Smith–Magenis Syndrome. J Autism Dev Disord. 2006;36:541–52.
    1. Thurman AJ, Fisher MH. The Williams syndrome social phenotype: disentangling the contributions of social interest and social difficulties. Int Rev Res Dev Disabil. 2015;49:191–227.
    1. Abbeduto L, Warren SF, Conners FA. Language development in Down syndrome: from the prelinguistic period to the acquisition of literacy. Ment Retard Dev Disabil Res Rev. 2007;13:247–61.
    1. Laws G, Bishop D. Pragmatic language impairment and social deficits in Williams syndrome: a comparison with Down’s syndrome and specific language impairment. Int J Lang Commun Disord. 2004;39:45–64.
    1. Lee NR, Lopez KC, Adeyemi EI, Giedd JN. Sex chromosome aneuploidies: a window for examining the effects of the X and Y chromosomes on speech, language, and social development. Int Rev Res Dev Disabil. 2011;40:139–80.
    1. Wolters PL, Gropman AL, Martin SC, Smith MR, Hildenbrand HL, Brewer CC, et al. Neurodevelopment of children under 3 years of age with Smith-Magenis syndrome. Pediatr Neurol. 2009;41:250–8.
    1. Bertelsen N, Landi I, Bethlehem RAI, Seidlitz J, Busuoli EM, Mandelli V, et al. Imbalanced social-communicative and restricted repetitive behavior subtypes of autism spectrum disorder exhibit different neural circuitry. Commun Biol. 2021;4:574.
    1. Boyd BA, McDonough SG, Bodfish JW. Evidence-based behavioral interventions for repetitive behaviors in autism. J Autism Dev Disord. 2012;42:1236–48.
    1. Robinson EB, Koenen KC, McCormick MC, Munir K, Hallett V, Happe F, et al. Evidence that autistic traits show the same etiology in the general population and at the quantitative extremes (5%, 2.5%, and 1%) Arch Gen Psychiatry. 2011;68:1113–21.
    1. Houghton R, Liu C, Bolognani F. Psychiatric comorbidities and psychotropic medication use in autism: a Matched Cohort Study with ADHD and general population comparator groups in the United Kingdom. Autism Res. 2018;11:1690–700.
    1. Olsen L, Sparso T, Weinsheimer SM, Dos Santos MBQ, Mazin W, Rosengren A, et al. Prevalence of rearrangements in the 22q11.2 region and population-based risk of neuropsychiatric and developmental disorders in a Danish population: a case-cohort study. Lancet Psychiatry. 2018;5:573–80.
    1. Esbensen AJ, Hooper SR, Fidler D, Hartley SL, Edgin J, d’Ardhuy XL, et al. Outcome measures for clinical trials in Down syndrome. Am J Intellect Dev Disabil. 2017;122:247–81.
    1. Kaat AJ, Farmer C. Commentary: lingering questions about the Social Responsiveness Scale short form. A commentary on Sturm et al. (2017) J Child Psychol Psychiatry. 2017;58:1062–4.

Source: PubMed

3
Abonnieren